Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study - Kinlay, S; Schwartz, GG; Olsson, AG (Circulation, 2004)
et al.